Stay updated on Intranasal Etripamil Safety Study for PSVT Clinical Trial
Sign up to get notified when there's something new on the Intranasal Etripamil Safety Study for PSVT Clinical Trial page.

Latest updates to the Intranasal Etripamil Safety Study for PSVT Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThese publications are automatically filled from PubMed and may not all be about the study; the revision identifier was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding/operating status notice was removed from the page, a generic site-wide alert that did not affect the study details or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedNo substantive changes detected between the two screenshots. The page still centers on the NODE-302 safety study of etripamil nasal spray for PSVT.SummaryDifference0.3%

- Check71 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference3%

- Check78 days agoChange DetectedUpdated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new release version.SummaryDifference0.1%

- Check93 days agoChange DetectedUpdated to v3.0.2 and removed the Back to Top link. No substantive changes to core content, pricing, stock, or time slot availability.SummaryDifference0.2%

Stay in the know with updates to Intranasal Etripamil Safety Study for PSVT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Etripamil Safety Study for PSVT Clinical Trial page.